MoneyWorks4Me

Zenlabs Ethica informs about disclosure

21 Jun 2022 Evaluate

Zenlabs Ethica has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Preet Remedies.

The above information is a part of company’s filings submitted to BSE.


Peers